0001209191-18-056052.txt : 20181024
0001209191-18-056052.hdr.sgml : 20181024
20181024162036
ACCESSION NUMBER: 0001209191-18-056052
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181022
FILED AS OF DATE: 20181024
DATE AS OF CHANGE: 20181024
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TUFTS LINDA
CENTRAL INDEX KEY: 0001388680
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38697
FILM NUMBER: 181136632
MAIL ADDRESS:
STREET 1: 222 BERKELEY STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001169245
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 030375697
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY
STREET 2: SUITE 30
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (610) 981-6500
MAIL ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY
STREET 2: SUITE 30
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER COMPANY:
FORMER CONFORMED NAME: Phase Biosciences Inc
DATE OF NAME CHANGE: 20061013
FORMER COMPANY:
FORMER CONFORMED NAME: DT BIOSCIENCES INC
DATE OF NAME CHANGE: 20020315
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-10-22
0
0001169245
PhaseBio Pharmaceuticals Inc
PHAS
0001388680
TUFTS LINDA
C/O PHASEBIO PHARMACEUTICALS, INC.
1 GREAT VALLEY PARKWAY, SUITE 30
MALVERN
PA
19355
1
0
0
0
Common Stock
2018-10-22
4
C
0
577486
A
577486
I
By Fletcher Spaght Ventures II, LP
Common Stock
2018-10-22
4
P
0
12682
5.00
A
590168
I
By Fletcher Spaght Ventures II, LP
Common Stock
2018-10-22
4
C
0
58152
A
58152
I
By FSV II, LP
Common Stock
2018-10-22
4
P
0
1277
5.00
A
59429
I
By FSV II, LP
Common Stock
2018-10-22
4
C
0
275055
A
275055
I
By FSV II-B, LP
Common Stock
2018-10-22
4
P
0
6041
5.00
A
281096
I
By FSV II-B, LP
Warrants to Purchase Series B Preferred Stock
0.12
2018-10-22
4
M
0
7053
0.00
D
Series B Preferred Stock
7053
0
I
By Fletcher Spaght Ventures II, LP
Series B Preferred Stock
2018-10-22
4
M
0
7053
0.12
A
Common Stock
7053
347420
I
By Fletcher Spaght Ventures II, LP
Series B Preferred Stock
2018-10-22
4
S
0
170
5.00
D
Common Stock
170
347250
I
By Fletcher Spaght Ventures II, LP
Warrants to Purchase Series B Preferred Stock
0.12
2018-10-22
4
M
0
710
0.00
D
Series B Preferred Stock
710
0
I
By FSV II, LP
Series B Preferred Stock
2018-10-22
4
M
0
710
0.12
A
Common Stock
710
34986
I
By FSV II, LP
Series B Preferred Stock
2018-10-22
4
S
0
18
5.00
D
Common Stock
18
34968
I
By FSV II, LP
Warrants to Purchase Series B Preferred Stock
0.12
2018-10-22
4
M
0
3359
0.00
D
Series B Preferred Stock
3359
0
I
By FSV II-B, LP
Series B Preferred Stock
2018-10-22
4
M
0
3359
0.12
A
Common Stock
3359
165476
I
By FSV II-B, LP
Series B Preferred Stock
2018-10-22
4
S
0
81
5.00
D
Common Stock
81
165395
I
By FSV II-B, LP
Warrants to Purchase Series C-1 Preferred Stock
0.12
2018-10-22
4
M
0
9847
0.00
D
Series C-1 Preferred Stock
9847
0
I
By Fletcher Spaght Ventures II, LP
Series C-1 Preferred Stock
2018-10-22
4
M
0
9847
0.12
A
Common Stock
9847
47377
I
By Fletcher Spaght Ventures II, LP
Series C-1 Preferred Stock
2018-10-22
4
S
0
237
5.00
D
Common Stock
237
47140
I
By Fletcher Spaght Ventures II, LP
Warrants to Purchase Series C-1 Preferred Stock
0.12
2018-10-22
4
M
0
991
0.00
D
Series C-1 Preferred Stock
991
0
I
By FSV II, LP
Series C-1 Preferred Stock
2018-10-22
4
M
0
991
0.12
A
Common Stock
991
4770
I
By FSV II, LP
Series C-1 Preferred Stock
2018-10-22
4
S
0
24
5.00
D
Common Stock
24
4746
I
By FSV II, LP
Warrants to Purchase Series C-1 Preferred Stock
0.12
2018-10-22
4
M
0
4690
0.00
D
Series C-1 Preferred Stock
4690
0
I
By FSV II-B, LP
Series C-1 Preferred Stock
2018-10-22
4
M
0
4690
0.12
A
Common Stock
4690
22565
I
By FSV II-B, LP
Series C-1 Preferred Stock
2018-10-22
4
S
0
113
5.00
D
Common Stock
113
22452
I
By FSV II-B, LP
Series AA Preferred Stock
2018-10-22
4
C
0
119408
0.00
D
Common Stock
119408
0
I
By Fletcher Spaght Ventures II, LP
Series AA Preferred Stock
2018-10-22
4
C
0
12025
0.00
D
Common Stock
12025
0
I
By FSV II, LP
Series AA Preferred Stock
2018-10-22
4
C
0
56874
0.00
D
Common Stock
56874
0
I
By FSV II-B, LP
Series B Preferred Stock
2018-10-22
4
C
0
347250
0.00
D
Common Stock
347250
0
I
By Fletcher Spaght Ventures II, LP
Series B Preferred Stock
2018-10-22
4
C
0
34968
0.00
D
Common Stock
34968
0
I
By FSV II, LP
Series B Preferred Stock
2018-10-22
4
C
0
165395
0.00
D
Common Stock
165395
0
I
By FSV II-B, LP
Series C-1 Preferred Stock
2018-10-22
4
C
0
47140
0.00
D
Common Stock
47140
0
I
By Fletcher Spaght Ventures II, LP
Series C-1 Preferred Stock
2018-10-22
4
C
0
4746
0.00
D
Common Stock
4746
0
I
By FSV II, LP
Series C-1 Preferred Stock
2018-10-22
4
C
0
22452
0.00
D
Common Stock
22452
0
I
By FSV II-B, LP
Series D Preferred Stock
2018-10-22
4
C
0
63688
0.00
D
Common Stock
63688
0
I
By Fletcher Spaght Ventures II, LP
Series D Preferred Stock
2018-10-22
4
C
0
6413
0.00
D
Common Stock
6413
0
I
By FSV II, LP
Series D Preferred Stock
2018-10-22
4
C
0
30334
0.00
D
Common Stock
30334
0
I
By FSV II-B, LP
Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.
FSA II, LLC is the general partner of the general partner of Fletcher Spaght Ventures II, LP and FSV II-B, LP and the manager of the general partner of FSV II, LP. The reporting person is a managing member of FSA II, LLC and disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein.
Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering.
The warrants were exercisable until, and were scheduled to expire upon, the closing of the Issuer's initial public offering.
/s/ Darren K. DeStefano, Attorney-in-Fact
2018-10-24